Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Programmable bio-nanochip technology for the diagnosis of cardiovascular disease at the point-of-care.

Christodoulides N, Pierre FN, Sanchez X, Li L, Hocquard K, Patton A, Muldoon R, Miller CS, Ebersole JL, Redding S, Yeh CK, Furmaga WB, Wampler DA, Bozkurt B, Ballantyne CM, McDevitt JT.

Methodist Debakey Cardiovasc J. 2012 Jan;8(1):6-12. Review. Erratum in: Methodist Debakey Cardiovasc J. 2012 Jul-Sep;8(3):48.

2.

Challenges and opportunities for translating medical microdevices: insights from the programmable bio-nano-chip.

McRae MP, Simmons G, McDevitt JT.

Bioanalysis. 2016 May;8(9):905-19. doi: 10.4155/bio-2015-0023. Epub 2016 Apr 13.

3.

Programmable Bio-nanochip Platform: A Point-of-Care Biosensor System with the Capacity To Learn.

McRae MP, Simmons G, Wong J, McDevitt JT.

Acc Chem Res. 2016 Jul 19;49(7):1359-68. doi: 10.1021/acs.accounts.6b00112. Epub 2016 Jul 6.

PMID:
27380817
4.

Programmable bio-nano-chip systems for serum CA125 quantification: toward ovarian cancer diagnostics at the point-of-care.

Raamanathan A, Simmons GW, Christodoulides N, Floriano PN, Furmaga WB, Redding SW, Lu KH, Bast RC Jr, McDevitt JT.

Cancer Prev Res (Phila). 2012 May;5(5):706-16. doi: 10.1158/1940-6207.CAPR-11-0508. Epub 2012 Apr 9.

5.

Programmable bio-nano-chip system: a flexible point-of-care platform for bioscience and clinical measurements.

McRae MP, Simmons GW, Wong J, Shadfan B, Gopalkrishnan S, Christodoulides N, McDevitt JT.

Lab Chip. 2015 Oct 21;15(20):4020-31. doi: 10.1039/c5lc00636h. Epub 2015 Aug 26.

6.

Portable microfluidic and smartphone-based devices for monitoring of cardiovascular diseases at the point of care.

Hu J, Cui X, Gong Y, Xu X, Gao B, Wen T, Lu TJ, Xu F.

Biotechnol Adv. 2016 May-Jun;34(3):305-20. doi: 10.1016/j.biotechadv.2016.02.008. Epub 2016 Feb 18. Review.

PMID:
26898179
7.

Point-of-care oral-based diagnostics.

Hart RW, Mauk MG, Liu C, Qiu X, Thompson JA, Chen D, Malamud D, Abrams WR, Bau HH.

Oral Dis. 2011 Nov;17(8):745-52. doi: 10.1111/j.1601-0825.2011.01808.x. Epub 2011 Apr 26. Review.

8.

Lab-on-a-chip based immunosensor principles and technologies for the detection of cardiac biomarkers: a review.

Mohammed MI, Desmulliez MP.

Lab Chip. 2011 Feb 21;11(4):569-95. doi: 10.1039/c0lc00204f. Epub 2010 Dec 23. Review.

PMID:
21180774
9.

Programmable nano-bio-chips: multifunctional clinical tools for use at the point-of-care.

Jokerst JV, McDevitt JT.

Nanomedicine (Lond). 2010 Jan;5(1):143-55. doi: 10.2217/nnm.09.94. Erratum in: Nanomedicine (Lond). 2013 Jan;8(1):160.

10.

Translational and clinical applications of salivary diagnostics.

Giannobile WV, McDevitt JT, Niedbala RS, Malamud D.

Adv Dent Res. 2011 Oct;23(4):375-80. doi: 10.1177/0022034511420434.

11.

Salivary biomarkers--an update.

Shankar AA, Dandekar RC.

Dent Update. 2012 Oct;39(8):566-8, 571-2.

PMID:
23167205
12.

Cardiac markers: a clear cause for point-of-care testing.

Friess U, Stark M.

Anal Bioanal Chem. 2009 Mar;393(5):1453-62. doi: 10.1007/s00216-008-2573-z. Epub 2009 Jan 16. Review.

PMID:
19148628
13.

A multiplexable, microfluidic platform for the rapid quantitation of a biomarker panel for early ovarian cancer detection at the point-of-care.

Shadfan BH, Simmons AR, Simmons GW, Ho A, Wong J, Lu KH, Bast RC Jr, McDevitt JT.

Cancer Prev Res (Phila). 2015 Jan;8(1):37-48. doi: 10.1158/1940-6207.CAPR-14-0248. Epub 2014 Nov 11.

14.

Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker.

Moons KG, Kengne AP, Woodward M, Royston P, Vergouwe Y, Altman DG, Grobbee DE.

Heart. 2012 May;98(9):683-90. doi: 10.1136/heartjnl-2011-301246. Epub 2012 Mar 7. Review.

PMID:
22397945
15.

Highly-integrated lab-on-chip system for point-of-care multiparameter analysis.

Schumacher S, Nestler J, Otto T, Wegener M, Ehrentreich-Förster E, Michel D, Wunderlich K, Palzer S, Sohn K, Weber A, Burgard M, Grzesiak A, Teichert A, Brandenburg A, Koger B, Albers J, Nebling E, Bier FF.

Lab Chip. 2012 Feb 7;12(3):464-73. doi: 10.1039/c1lc20693a. Epub 2011 Oct 28.

PMID:
22038328
16.

Current developments in salivary diagnostics.

Miller CS, Foley JD, Bailey AL, Campell CL, Humphries RL, Christodoulides N, Floriano PN, Simmons G, Bhagwandin B, Jacobson JW, Redding SW, Ebersole JL, McDevitt JT.

Biomark Med. 2010 Feb;4(1):171-89. Review.

17.

Candidate circulating biomarkers for the cardiovascular disease continuum.

Dotsenko O, Chackathayil J, Patel JV, Gill PS, Lip GY.

Curr Pharm Des. 2008;14(24):2445-61. Review.

PMID:
18781994
18.

Oral fluid nanosensor test: saliva as a diagnostic tool for oral health.

Pujari M, Bahirwani S, Balaji P, Kaul R, Shah B, Daryani D, Iqbal S.

J Calif Dent Assoc. 2012 Sep;40(9):733-6. Review.

PMID:
23097828
19.

Early and late outcome prediction of death in the emergency room setting by point-of-care and laboratory assays of cardiac troponin I.

Venge P, Ohberg C, Flodin M, Lindahl B.

Am Heart J. 2010 Nov;160(5):835-41. doi: 10.1016/j.ahj.2010.07.036.

PMID:
21095269
20.

Point-of-care platforms for salivary diagnostics.

Wei F, Wong DT.

Chin J Dent Res. 2012;15(1):7-15.

Supplemental Content

Support Center